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dataset will evolve over time as more data become available. 
Secondly, “classical” trial end points such as overall and 
progression free survival may not be the most appropriate 
outcome measures in elderly-specific trials. Given the limited 
life expectancy, QoL is essential to take into account, and 
also, cost-effectiveness will be different from the general 
population. This makes quality adjusted survival, measured in 
quality adjusted life years (QALYs), a more suitable end 
point, allowing the answer to both questions: it reflects both 
the quantity of lifetime gained and the value of this time, 
and it provides a direct outcome measure to calculate the 
cost-effectiveness of the treatment. In order to calculate 
QALYs, utility scores should be collected prospectively. The 
EuroQoL 5 Dimensions (EQ-5D), a short questionnaire 
consisting of five questions, is most frequently used for this 
purpose.  
General and disease specific quality of life, toxicity and 
preservation of functional capacity are interesting secondary 
end points, scored with a uniform and internationally 
acknowledged scoring system. The additional use of the 
elderly specific questionnaire EORTC QLQ-ELD15 is 
recommended, which has recently been validated 
internationally (Wheelwright, Br J Cancer 2013).   
Results from surveys indicate that the large majority of 
elderly patients would be willing to participate in trials 
(Comis, JCO 2003; Townsley BMC Cancer 2006), but care 
should be taken to limit the complexity of the trial design 
and burden of study related examinations. 
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Purpose/Objective: Online adaptive MR-IGRT was recently 
implemented at our institution. We report workflow 
considerations and initial clinical experience with online 
adaptive MR-IGRT for abdominopelvic malignancies. 
Materials and Methods: The first clinically deployed online 
adaptive MR-IGRT system consists of a split 0.35T MR scanner 
straddling a ring gantry with three MLC-equipped 60Co heads. 
The unit is supported by a fast Monte Carlo based treatment 
planning system allowing real-time adaptive planning with 
the patient on the table. All patients undergo CT- and MR-
simulation for initial treatment planning. A high-resolution 
volumetric MR image is acquired for each patient at the time 
of daily treatment setup. Deformable registration is 
performed using the original simulation CT dataset from 
initial treatment planning, which allows the transfer of the 
initial contours and the electron density map to the 
localization MR of the day. The deformed electron density 
map is then used to recalculate the original plan on the 
anatomy of the day for physician evaluation. Physician re-
contouring and plan re-optimization are performed when 
required, and patient-specific quality assurance is performed 
using an independent Monte Carlo calculation for online 
adaptive QA. The tool also allows for verification of plan 
parameters against the original plan. 
Results: Online adaptive MR-IGRT was implemented in 
September of 2014. Five patients with abdominopelvic 
malignancies have been treated with planned evaluation for 
treatment adaptation in the first 2 months. The clinical 
setting included neoadjuvant rectosigmoid (n=3), 
unresectable gastric, and unresectable pheochromocytoma. 
MR localization images were used to recalculate dose online 
for all cases. Re-contouring and re-optimization was deemed 
necessary for 3/5, while the initial plan deemed sufficient for 
2/5 cases. Reasons for plan adaptation included change in 
target size, weight loss, and change in small bowel anatomy. 
The approximate times required for online dose calculation, 
re-contouring, re-optimization, and QA were 2, 15, 2, and 5 
minutes, respectively. Treatment utilizing the online 
adaptive plan was completed successfully for all cases when 
deemed necessary. 
Conclusions: Online adaptive MR-IGRT has been successfully 
implemented with planning and QA workflow suitable for 
routine clinical application. Clinical trials are in development 
to formally evaluate adaptive treatment of bladder, 
pancreatic, and oligometastatic abdominal malignancies. 
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Purpose/Objective: Several authors have recommended a 2 
mm tolerance for MLC positioning in sliding window 
treatments. A tolerance of 5mm is typically used in VMAT 
treatments, but the optimal value for this technique remains 
unknown. In this paper we present the results of a 
multicentric study to determine the optimal tolerance for 
both techniques. 
Materials and Methods: The procedure used to investigate 
the optimal tolerance is based on dynalog file analysis. The 
study was performed with seven Varian linear accelerators 
(linacs) (Varian Medical Systems, Inc., Palo Alto, CA) from 
five different centers. All linacs were equipped with dynamic 
MLCs: six with the Millennium120 model and one with the 
high definition HD120 model. Dynalogs were collected from 
over 100,000 clinical treatments and an in-house software 
was developed for dynalog analysis. By using this software 
the number of tolerance faults was computed as a function of 
the user-defined tolerance and the optimal value for this 
tolerance tolerance –defined as the lowest achievable value- 
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was investigated for both sliding window and VMAT 
techniques (RapidArcTM technology). 
Results: Dynalog files premit to predict the number of 
tolerance faults as a function of the tolerance value, with 
accurate predictions for low incidences of tolerance faults. 
All MLCs presented a very similar behavior, with no 
significant difference between the Millennium120 and the 
HD120 models. In sliding window techniques the number of 
beams with an incidence of hold-offs >1% rapidly decreases 
for a tolerance ~1.5 mm. It is to remark that most of the 
beam hold-offs (>97%) produced in sliding window beams with 
the 2 mm tolerance were caused by the maximum leaf speed 
specification not being properly taken into account in the 
treatment planning process. In VMAT techniques the number 
of tolerance faults sharply drops for tolerances around 2 mm. 
For a tolerance of 2.5 mm less than 0.1% of the VMAT arcs 
presented tolerance faults. 
 
Conclusions: Dynalog analysis provides a feasible method to 
investigate the optimal tolerance for MLC positioning in 
dynamic fields. In sliding window treatments the tolerance of 
2 mm was found to be adequate. However, to further 
guarantee the accuracy of treatment delivery, this tolerance 
could be reduced to 1.5 mm. In VMAT treatments the 
typically used 5 mm tolerance is excessively high. Instead, a 
tolerance of 2.5 mm is recommended.  
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Purpose/Objective: To replace the multitude of devices with 
a singular one that measures and records all mechanical, 
optical and relative dosimetry parameters associated with 
the monthly quality assurance (QA) of external beam therapy 
and high dose rate (HDR) brachytherapy systems. 
Materials and Methods: The QA system consists of a novel 
multi-mirror assembly in a light-tight housing which directs 
images from a receptor plane for capture with an in-line 1.4 
mega-pixel CCD camera. The in-line camera simplifies cable 
management and is shielded against scattered and leakage 
radiation. The entire housing with the in-line camera is 
rotated under computer control to any desired position. A 
single 25 cm x 25 cm phosphor screen is used as the image 
receptor and is typically positioned at the machine iso-
center. Optical images of the room lasers, light field and 
optical distance indicator are transmitted through the semi-
transparent phosphor screen for capture by the camera. The 
CCD is operated with 0.5 sec integration for optical light 
imaging. For the QA of external beam radiation, a buildup 
plate is inserted on top of the phosphor screen which 
produces a 2D image of an irradiating x-ray or electron field 
for QA analysis. The CCD is operated with 20 sec integration 
for radiation imaging, appropriately corrected for dark 
current background. Relative QA of dosimetry parameters, 
such as flatness and symmetry, are made with respect to 
baseline measurements. Beam energy constancy checks were 
made using brass buildup plates with island filters. For the 
QA of HDR brachytherapy system, applicators are secured on 
surface of the phosphor screen where the dwelled positions 
of source are verified using the resultant fluorescence image.  
Results: The system provides high spatial resolution for QA at 
0.24 mm x 0.24 mm per pixel. The positioning accuracy of 
the multi-leaf collimator was determined to be well within 1 
mm using the picket fence method. The isocentricities of the 
collimator and table rotation were determined by the centers 
of mass (COM) of the resultant images of a small 2 cm x 2 cm 
rotated x-ray beam. The same COM method was used to 
determine the gantry radiation isocentricity by rotating the 
QA system in alignment with the gantry for radiation. The 
resultant 3D gantry radiation isocenter information cannot be 
measured with film star-shot. Beam energy constancy based 
on pixel intensities were within 1% for repeated runs. 
Planned and delivered dwell positions of HDR sources agreed 
to 1.2 mm +/- 0.5 mm. 
Conclusions: A single device has been successfully developed 
to unify all mechanical, optical and radiation QA 
measurements of the accelerator per recommendations of 
TG-142 of the AAPM. The time spent is reduced by two-third. 
The system can be applied for HDR source positioning QA. 
Most important, the system records and documents optical 
measurements that are now only evaluated visually which 
will strengthen the confidence for safe patient treatment.  
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Purpose/Objective: To systematically assess VMAT delivery 
accuracy and efficiency by means of log file based quality 
assurance using a dynamic benchmark test plan.  
Materials and Methods: The VMAT test plan was generated 
using iComCAT (Elekta) and delivered at 18 Elekta linacs (13 
Synergy with MLCi2, 5 Agility) in Friedrichshafen, Amsterdam, 
Vienna and Feldkirch. For the test plan, square field shapes 
with varying field size (0.5x0.5cm2 to 24x24cm2) and a full 
gantry rotation were generated. Control points were 
